NCT05743049Recruiting
Collection of Circulating Biomarkers in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Start Date
2/27/2023
Completion Date
1/15/2028
Summary
This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
* The subject must be a patient of the University of Pennsylvania
* The subject must be able to provide informed consent
* The subject must be 18 years of age or older
Exclusion Criteria:
. Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.
Interventions
OTHER
Obtaining blood for analysis of various circulating biomarkers
Conditions
Pancreas Cancer
Locations
Abramson Cancer Center at University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States